CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Novo Nordisk A/S - share repurchase programme

Neutral
AI Analysis

Summary

Novo Nordisk announced an update on its share repurchase programme initiated on 6 May 2026, with a total authorization of DKK 15 billion over a 12-month period beginning 4 February 2026.

Importance:3/10
Sentiment:
0.00
share repurchasecapital allocationshareholder return
Related Companies

Read the original article

Published by GlobeNewswire Pharma on September 7, 2026 11:12 AM

Read Original